课题基金 / 基金详情

Clarifying the pathogenesis of chronic hepatitis C through comprehensive genetic analyses of the virus and host using next-generation sequencer

Clarifying the pathogenesis of chronic hepatitis C through comprehensive genetic analyses of the virus and host using next-generation sequencer
使用下一代测序仪对病毒和宿主进行全面的遗传分析,阐明慢性丙型肝炎的发病机制
批准号:
23390195
负责人:
ENOMOTO Nobuyuki
金额:
$12.4万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2011
资助国家:
日本
项目状态:
已结题
起止时间:
2011-04-01 至 2014-03-31

项目摘要

项目成果

ENOMOTO Nobuyuki的其他基金

相似基金

相关文献

中文摘要
翻译
丙型肝炎病毒被认为存在于宿主体内,是各种病毒突变亚群的复杂混合物,称为“准种”。然而,由于技术上的限制,分析病毒准种及其在肝炎发病中的作用一直很困难。在这项研究中,通过引入革命性的新一代测序技术,我们揭示了准种状态及其动态与抗病毒治疗和肝癌发生有显著关联。
英文摘要
Hepatitis C virus has been considered to exist in a host as a complex mixture of various viral mutant subpopulations called as "quasispecies". However, analyzing viral quasispecies and its role in the pathogenesis of hepatitis has been difficult due to the technical limitation. In this study, through introducing the revolutionary technology of next-generation sequencing, we disclosed that the quasispecies state and its dynamics had a significant association with antiviral therapies as well as hepatocarcinogenesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1007/s00330-012-2571-6
发表时间: 2013-01-01
期刊: EUROPEAN RADIOLOGY
影响因子: 5.9
作者: [Motosugi, Utaroh, Ichikawa, Tomoaki, Araki, Tsutomu]
通讯作者: Araki, Tsutomu
Changes in plasma vascular endothelial growth factor at 8 weeks after sorafenib administration as predictors of survival for advanced hepatocellular carcinoma.
索拉非尼施用后8周,血浆血管内皮生长因子的变化是晚期肝细胞癌生存的预测指标。
DOI: 10.1002/cncr.28384
发表时间: 2014-01-15
期刊: CANCER
影响因子: 6.2
作者: [Tsuchiya, Kaoru, Asahina, Yasuhiro, Matsuda, Shuya, Muraoka, Masaru, Nakata, Toru, Suzuki, Yuichiro, Tamaki, Nobuharu, Yasui, Yutaka, Suzuki, Shoko, Hosokawa, Takanori, Nishimura, Takashi, Ueda, Ken, Kuzuya, Teiji, Nakanishi, Hiroyuki, Itakura, Jun, Takahashi, Yuka, Kurosaki, Masayuki, Enomoto, Nobuyuki, Izumi, Namiki]
通讯作者: Izumi, Namiki
DOI: 10.1371/journal.pone.0082299
发表时间: 2013
期刊: PloS one
影响因子: 3.7
作者: [Shen H, Yamashita A, Nakakoshi M, Yokoe H, Sudo M, Kasai H, Tanaka T, Fujimoto Y, Ikeda M, Kato N, Sakamoto N, Shindo H, Maekawa S, Enomoto N, Tsubuki M, Moriishi K]
通讯作者: Moriishi K
A new method for induced fit docking (GENIUS) and its application to virtual screening of novel HCV NS3-4A protease inhibitors
诱导拟合对接新方法(GENIUS)及其在新型HCV NS3-4A蛋白酶抑制剂虚拟筛选中的应用
DOI: 10.1016/j.bmc.2011.09.023
发表时间: 2011
期刊: Bioorganic & Medicinal Chemistry
影响因子: 3.5
作者: [Takaya D, Sakamoto N, et al.]
通讯作者: et al.
共 34 条
    Next-generation sequence of cancer-related genes in digestive organ cancers using clinical samples
    • 批准号:
      26670380
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2014
    • 负责人:
      ENOMOTO Nobuyuki
    • 依托单位:
    Analysis ofchronic viral hepaptis by the large-scale next generation sequeincing
    • 批准号:
      21659186
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.11万
    • 财政年份:
      2009
    • 负责人:
      ENOMOTO Nobuyuki
    • 依托单位:
    Comprehensive analysis of chronic hepatitis C by large-scale viral genome wide analysis
    • 批准号:
      20390206
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.98万
    • 财政年份:
      2008
    • 负责人:
      ENOMOTO Nobuyuki
    • 依托单位:
    Analysis of anti-interferon mechanism by HCV NS5A protein using HCV replicon system
    国内基金
    海外基金
    UDCA抑制G6PD活性诱导 HCC 细胞铁死亡的抗肝癌机制研究
    • 批准号:
      2026JJ82280
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      熊玉婕
    • 依托单位:
    NAFLD-HCC中去泛素化酶USP45稳定HK2促进糖酵解调控HCC细胞干性增殖功能的机制研究
    • 批准号:
      2026JJ80512
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      刘子儒
    • 依托单位:
    Wnt β-连环蛋白信号介导的肿瘤微环境免疫细胞浸润影响缺血再灌注损伤后HCC复发的作用机制研究
    • 批准号:
      2026JJ82621
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      余加
    • 依托单位:
    黄芪-莪术调控组氨酸代谢改善 DCs 功能与 Th1极化重塑 HCC 免疫微环境的机制研究
    • 批准号:
      ZCLMS26H2802
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      朱智慧
    • 依托单位: